The recent market rebound has brought a fresh wave of buying interest to several high-profile stocks, with Ross Stores, Howmet Aerospace, Krystal Biotech, Viking Holdings, and Bloom Energy emerging as key names to monitor next week. Each of these companies has shown unique catalysts, from revised earnings guidance to sector-specific tailwinds, positioning them for potential breakouts or pullbacks.
Ross Stores: Value Play with Strong Momentum
Ross Stores remains a top risk-reward candidate, trading at $240.13 with a P/E of about 33.5. The off-price retailer posted a 21% jump in first-quarter sales, with comparable-store sales rising 17% and EPS hitting $2.02, up 37% year over year. The company raised its full-year EPS guidance to a range of $7.50 to $7.74, reflecting confidence in ongoing consumer demand for value. Bulls point to increased foot traffic from budget-conscious shoppers, while bears caution that the stock's elevated valuation may already price in optimism. The next major catalyst will be second-quarter sales and any further guidance adjustments.
Howmet Aerospace: High-Flying Industrial Play
Howmet Aerospace, trading at $264.67 with a P/E above 61, benefits from robust demand in commercial aerospace, defense, and gas turbines. First-quarter revenue grew 19% to $2.31 billion, with adjusted EPS surging 42%. The company lifted its 2026 outlook, citing a 20% increase in commercial aerospace sales, 10% in defense, and 39% in gas turbines. Supporters highlight strong pricing power and capacity constraints, while detractors worry about a premium valuation that could be vulnerable to supply chain disruptions or margin compression. Second-quarter orders and margins will be key to sustaining the stock's upward trajectory.
Bloom Energy: High Risk, High Reward in AI Power
Bloom Energy, the most speculative of the group, last traded at $260.22, up 4.6%, with trailing earnings still negative. First-quarter revenue soared 130% to $751.1 million, driven by a 208% surge in product revenue. The company raised its 2026 revenue-growth target midpoint to roughly 80%, up from 60%, as demand for electricity from AI data centers and electrification accelerates. Bulls see Bloom as a key on-site power provider, but bears warn that a nearly 200% year-to-date gain leaves little room for error. The stock's next big test will be securing large-scale data-center power deals and proving consistent cash flow.
Krystal Biotech: Biotech with Rare-Disease Focus
Krystal Biotech, trading at $317.97 with a P/E around 42.6, relies on its rare-disease drug VYJUVEK, which posted first-quarter sales of $116.4 million, up 32%, with a 95% gross margin. The company holds about $1.0 billion in cash and investments. Bulls see potential for international expansion of high-margin profits, while bears cite typical biotech risks like clinical setbacks or pricing pressure. Key milestones include registrational trial results and European pricing or launch news expected in 2026.
Viking Holdings: Travel Demand Remains Strong
Viking Holdings shares slipped 1.1% to $92.25 after first-quarter revenue of $1.05 billion, up 17.5%, and adjusted EBITDA growth of 43.9% to $104.8 million. The company reported 92% of 2026 capacity sold and 38% of 2027 capacity booked, with advance bookings for 2027 tracking 31% higher year over year. Bulls point to sustained demand for high-end travel, but bears highlight cyclical risks from fuel prices, geopolitical shocks, or changing consumer sentiment. Investors will watch summer booking trends under new CEO Leah Talactac.
Overall, Ross Stores and Howmet Aerospace appear as the more straightforward buy candidates, backed by rising earnings and guidance. Bloom Energy and Krystal Biotech offer higher upside but with greater risk, while Viking Holdings sits in the middle with solid travel momentum but macro sensitivity. The coming week will test whether these stocks can maintain their breakouts or face profit-taking as valuations come under scrutiny.
